Name | Value |
---|---|
Revenues | 22.5K |
Cost of Revenue | 17.3K |
Gross Profit | 5.2K |
Operating Expense | 1,332.8K |
Operating I/L | -1,327.6K |
Other Income/Expense | -1.4K |
Interest Income | 0.0K |
Pretax | -1,328.9K |
Income Tax Expense | 1.4K |
Net Income/Loss | -1,330.3K |
Aclarion, Inc. is a healthcare technology company specializing in software applications for magnetic resonance spectroscopy (MRS) in the United States. The company's NOCISCAN-LS Post-Processor suite includes NOCICALC-LS, which processes disc MRS data to calculate levels of degenerative pain biomarkers, and NOCIGRAM-LS, a clinical decision support software. Aclarion, Inc. generates revenue by providing these software solutions to healthcare facilities and professionals, enabling them to analyze and interpret MRS data for diagnostic and treatment purposes.